Four companies drew the ire of the Food and Drug Administration this week for claiming that their marijuana-derived products can treat or cure cancer. The agency issued letters of warning, and threatened punitive action if the companies do not correct the violations.
A study presented at the 2017 Palliative and Supportive Care in Oncology Symposium examined the effects of early-integrated palliative care on patients with advanced/incurable lung or non-colorectal gastrointestinal cancers.
During the holiday season, cancer patients get a lot of well-intentioned but unhelpful advice. Here's how to make it stop.
Two-time cancer survivor offers ways to work toward happy.
Calquence (acalabrutinib) was granted an accelerated approval by the FDA to treat adult patients with mantle cell lymphoma (MCL) following at least one prior therapy. The approval was based on objective response rates (ORR) in a single-arm trial.
An advanced lung cancer diagnosis can be extremely stressful for patients and their loved ones, but a couples-based mindfulness intervention may be able to help.
Cancer is filled with a ton of crazy terms that doctors like me often have to translate.
The role of being a healthy caregiver involves knowing when to put the oxygen mask on.
Surviving cancer just got easier, thanks to these angels.
More patients with non-small cell lung cancer (NSCLC) should be evaluated and referred to clinical trials, especially those who may have molecular abnormalities, says Victoria M. Villaflor, M.D.
For those with hepatitis B, taking an aspirin once a day could reduce the risk of getting liver cancer.
Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.
If approved, the new indication would make frontline Avastin available in combination with carboplatin and paclitaxel, followed by Avastin alone, for women with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. The FDA is expected to render a decision on the sBLA by June 25, 2018.
What happens when the hustle, bustle, attention and care of active treatment end? Survivor shares what helped.
A cancer survivor weighs his losses and gains.
While the use of Jakafi (ruxolitinib) is firmly rooted in the treatment paradigm for patients with myelofibrosis, other novel agents, such as momelotinib and pacritinib are also gaining the interest of researchers in the field.
Chemotherapy-induced nausea and vomiting (CINV) is a common — and often costly — problem among patients with cancer.
Did a miracle occur after Mary Jane passed away from ovarian cancer?
Two-time cancer survivor talks about managing fatigue.
A free two-day workshop will train people who want to raise awareness of liver diseases and influence public health policy to address their concerns.
A new agent will soon be available to treat chemotherapy-induced nausea and vomiting.
Cancer weight is the pits!
Cancer survivor comments on life in an emptying nest.
Scientists in the lab and in the clinic can help patients with metastatic breast cancer make informed choices.
